natgillin/translations-raw huggingface dataset:
The recommended treatment dose of 20 mg per day is achieved by a gradual increase of the Memantine Merz dose during the first 3 weeks of treatment.
Priporočeni zdravilni odmerek 20 mg na dan se doseže s postopnim povečevanjem odmerka zdravila Memantine Merz med prvimi tremi tedni zdravljenja.
The recommended treatment dose of 20 mg per day is achieved by a gradual increase of the Memantine ratiopharm dose during the first 3 weeks of treatment.
Priporočeni zdravilni odmerek 20 mg na dan, se doseže s postopnim povečevanjem odmerka zdravila Memantin ratiopharm v prvih treh tednih zdravljenja.
The recommended treatment dose of 20 mg per day is achieved by a gradual increase of the Nemdatine dose during the first 3 weeks of treatment.
Za odrasle in starejše je priporočeni odmerek zdravila Nemdatine 20 mg enkrat dnevno.
The recommended treatment dose of 20mg per day is achieved by a gradual increase of the Memantine Accord dose during the first 3weeks of treatment.
Priporočeni zdravilni odmerek 20 mg na dan se doseže s postopnim povečevanjem odmerka zdravila Memantin Accord med prvimi tremi tedni zdravljenja.
The recommended treatment duration is 6 weeks .
Priporočen čas zdravljenja je 6 tednov.
The recommended Trudexa induction dose regimen for adult patients with severe Crohn’s disease is 80 mg at week 0 followed by 40 mg at week 2.
Priporočena shema odmerjanja Trudexe med indukcijo je pri odraslih bolnikih s hudo Crohnovo boleznijo 80 mg 0. teden in nato 40 mg 2. teden.
The recommended usual daily dose is Exelon 9.5 mg/24 h.
Priporočeni običajni dnevni odmerek zdravila Exelon je 9,5 mg/24 h.
The recommended usual daily dose is Prometax 9.5 mg/24 h.
Priporočeni običajni dnevni odmerek zdravila Prometax je 9,5 mg/24 h.
The recommended vaccination schedule for Infanrix hexa is two or three doses, given at least one month apart, usually within the first six months of life.
Priporočena shema cepljenja za cepivo Infanrix hexa sta dva ali trije odmerki, ki se dajo v presledku vsaj enega meseca, običajno v prvih šestih mesecih življenja.
The recommended volume for 1 dose is between 0.1 and 0.5 ml.
Priporočljiva količina za 1 odmerek je med 0,1 in 0,5 ml.
The recommended weekly dose
Priporočeni tedenski odmerek
The recommended weekly dose in children (i.e.
Priporočenega tedenskega odmerka za otroke (tj.
The recommended weight-based paediatric dose is dependent upon the patient’s age, with different recommended doses for children from 3 to < 8 years of age and children 8 years or older.
Priporočeni otroški odmerek, določen na podlagi telesne mase, je odvisen od bolnikove starosti in se razlikuje za otroke od 3. do 8. leta in starejše od 8. leta starosti.
The reconstituted and diluted solution is stable for up to 24 hours at room temperature (15C to 25C) and daylight exposure in standard polyethylene (PE) infusion bags.
Rekonstituirana in razredčena raztopina ostane stabilna 24 ur, če je shranjena pri sobni temperaturi (15 °C do 25 °C) in izpostavljena dnevni svetlobi v standardnih vrečkah za infundiranje iz polietilena (PE).
The reconstituted concentrate in the vial contains 20 mg/ml dalbavancin.
Rekonstituiran koncentrat v viali vsebuje 20 mg/ml dalbavancina.
The reconstituted concentrate must be further diluted with 50 mg/ml (5 %) glucose solution for infusion.
Rekonstituiran koncentrat mora biti v nadaljevanju še razredčen s 50 mg/ml (5 %) raztopine glukoze za infundiranje.
The reconstituted content shall be a milky emulsion.
Rekonstituirno cepivo je mlečno bela emulzija.
The reconstituted Kadcyla solution diluted in infusion bags containing sodium chloride 9 mg/ml (0.9%) solution for infusion, or sodium chloride 4.5 mg/ml (0.45%) solution for infusion, is stable for up to 24 hours at 2°C to 8°C, provided it was prepared under controlled and validated aseptic conditions.
Pripravljena raztopina zdravila Kadcyla, razredčena v infuzijski vrečki z 0,9-% (9 mg/ml) raztopino natrijevega klorida za infundiranje ali 0,45-% (4,5 mg/ml) raztopino natrijevega klorida za infundiranje, je stabilna do 24 ur pri temperaturi od 2 do 8 °C, če je bila pripravljena v nadzorovanih in preverjenih aseptičnih pogojih.
The reconstituted Kadcyla solution should be diluted in polyvinyl chloride (PVC) or latex-free PVC-free polyolefin infusion bags.
Pripravljena raztopina zdravila Kadcyla se lahko razredči v infuzijskih vrečkah iz polivinilklorida (PVC) ali brezlateksnega brez-PVC poliolefina.
The reconstituted NovoThirteen should be injected at a rate not higher than 2 ml/minute.
Pripravljeno zdravilo NovoThirteen je treba injicirati s hitrostjo, ki ne presega 2 ml/minuto.
The reconstituted pen can be stored for no more than 8 hours before continuing to Step B. Once the needle is attached the pen must be used immediately.
Pripravljeni peresnik morate uporabiti v 8 urah, preden nadaljujete s korakom B. Ko je na peresnik nameščena igla, ga morate uporabiti takoj.
The reconstituted preparation is a clear and colourless to slightly yellow solution
Rekonstituirani pripravek je prozorna, brezbarvna do rumenkasta raztopina.
The reconstituted product is isotonic.
Pripravljeno zdravilo je izotonično.
The reconstituted product is preservative free and should be used immediately after preparation.
Rekonstituirana raztopina ne vsebuje konzervansov in ga je treba porabiti takoj po raztapljanju.
The reconstituted product is preservative free and should be used immediately after preparation.
Rekonstituirana raztopina ne vsebuje konzervansov in jo je treba porabiti takoj po pripravi.
The reconstituted product is preservative free and should be used immediately after preparation.
Rekonstituirana raztopina ne vsebuje konzervansov in jo je treba porabiti takoj po raztapljanju.
The reconstituted product must be filtered prior to administration to remove potential particulate matter in the solution.
Rekonstituirano zdravilo je treba pred aplikacijo filtrirati, da se odstrani morebitne delce v raztopini.
The reconstituted product should be injected subcutaneously once daily for 5 consecutive days.
Rekonstiturano zdravilo je treba injicirati subkutano enkrat na dan 5 dni zapored.
The reconstituted product should be used immediately (up to 24 hours if prepared aseptically), and should not be frozen or refrigerated.
Pripravljeno zdravilo je treba uporabiti takoj (v roku 24 ur, če je bilo pripravljeno z uporabo aseptične tehnike) in se ga ne sme zamrzovati ali shranjevati v hladilniku.
The reconstituted product should preferably be used immediately.
Pripravljeno zdravilo je najbolje uporabiti takoj.
The reconstituted solution can be diluted with:
Pripravljeno (rekonstituirano) raztopino je mogoče redčiti z:
The reconstituted solution cannot be stored and should be promptly diluted.
Rekonstituirane raztopine ne shranjujte, ampak jo takoj razredčite.
The reconstituted solution contains 1 mg of stavudine per ml.
Pripravljena raztopina vsebuje 1 mg stavudina na mililiter.
The reconstituted solution contains 1 mg of stavudine per ml.
Pripravljena raztopina vsebuje 1 mg stavudina na ml.
The reconstituted solution contains 1 U reteplase per ml.
Pripravljena raztopina vsebuje 1 enoto reteplaze na ml.
The reconstituted solution contains 24 mg/ml docetaxel and should be used immediately after preparation.
Pripravljena raztopina vsebuje 24 mg/ml docetaksela in jo je treba uporabiti takoj po pripravi.
The reconstituted solution contains 5 mg agalsidase beta per ml, and appears as a clear colourless solution.
Rekonstituirana raztopina vsebuje 5 mg agalzidaze beta na ml in je videti kot bistra brezbarvna raztopina. pH vrednost rekonstituirane raztopine je približno 7,0.
The reconstituted solution contains approximately 24 mg/ml docetaxel and should be used immediately after preparation.
Pripravljena raztopina vsebuje približno 24 mg/ml docetaksela in jo je treba uporabiti nemudoma po pripravi.
The reconstituted solution contains approximately 24 mg/ml docetaxel and should be used immediately after preparation.
Pripravljena raztopina vsebuje približno 24 mg/ml docetaksela in jo je treba uporabiti takoj po pripravi.
The reconstituted solution contains ~ 24 mg/ml docetaxel, corresponding with an extractable volume of approximately
Pripravljena raztopina vsebuje približno ~ 24 mg/ml docetaksela, kar ustreza izločeni količini od približno
The reconstituted solution has a pH of approximately 6.0.
Pripravljena raztopina ima pH približno 6,0.
The reconstituted solution in each vial should be inspected for particulate matter and discoloration.
Rekonstituirano raztopino v vsaki viali je treba vizualno pregledati glede trdnih delcev in spremembe barve.
The reconstituted solution is a clear to slightly opalescent, colourless to pale yellow solution, and should not be administered if it contains particles or is not clear.
Rekonstituirana raztopina je bistra do rahlo opalescentna, brezbarvna do bledo rumena raztopina in je ne smete uporabiti, če vsebuje delce ali ni bistra.
The reconstituted solution is administered subcutaneously through the thighs (right or left) or abdomen (right or left).
Rekonstituirano raztopino injiciramo subkutano v stegno (desno ali levo) ali trebuh (desno ali levo).
The reconstituted solution is colourless to slightly yellow, and clear to very opalescent.
Rekonstituirana raztopina je brezbarvna do rahlo rumena in bistra do zelo opalescentna.
The reconstituted solution is hypotonic and must be further diluted prior to administration with 500 ml sodium chloride 9 mg/ml (0.9%) solution for injection (1000 ml if the dose is higher than 500 mg) or with an appropriate volume of sodium chloride 9 mg/ml (0.9%) in order to obtain a final TEPADINA concentration between 0.5 and 1 mg/ml.
Rekonstituirana raztopina je hipotonična in jo je treba pred uporabo nadalje razredčiti z dodajanjem 500 ml raztopine natrijevega klorida 9 mg/ml (0,9 %) za injiciranje (če je predpisan odmerek večji od 500 mg, uporabite 1000 ml) ali z ustrezno količino natrijevega klorida 9 mg/ml (0,9 %), da dosežeto končno koncentracijo zdravila TEPADINA med 0.5 in 1 mg/ml.
The reconstituted solution is isotonic.
Pripravljena raztopina je izotonična.
The reconstituted solution is physically-chemically stable for 24 hours at 25ºC.
Pripravljena raztopina je fizikalno in kemijsko stabilna 24 ur pri 25 ºC.
The reconstituted solution is preservative free and should be used immediately after preparation.
Rekonstituirana raztopina ne vsebuje konzervansov in ga je treba porabiti takoj po raztapljanju.
The reconstituted solution is preservative free and should be used immediately after preparation.
Rekonstituirana raztopina ne vsebuje konzervansov in jo je treba porabiti takoj po pripravi.
The reconstituted solution is preservative free and should be used immediately after preparation.
Rekonstituirana raztopina ne vsebuje konzervansov in jo je treba porabiti takoj po raztapljanju.
The reconstituted solution is stable for 1 month if stored at 2C – 8C (in a refrigerator)
Pripravljena raztopina je stabilna do 1 meseca, če jo shranjujemo pri temperaturi med 2 C in 8 C (v hladilniku)
The reconstituted solution is stable for 2 days when stored at 2 °C – 8 °C. If the medicine is not used immediately, the user preparing this medicine is responsible for storage times and conditions to ensure sterility of the product.
Rekonstituirana raztopina je stabilna 2 dni, če jo hranimo pri 2 °C-8 °C. Če se zdravilo ne uporabi takoj, je za trajanje shranjevanja in razmere, s katerimi se zagotavlja sterilnost zdravila, odgovoren uporabnik, ki pripravlja to zdravilo.
The reconstituted solution is stable for 24 hours at 2°C – 8°C. MAH logo
Rekonstituirana raztopina je stabilna 24 ur pri 2 °C – 8 °C. logotip imetnika dovoljenja za promet z zdravilom
The reconstituted solution is stable for 3 days at 20°C-25°C stored in the original vial and/or a syringe.
Rekonstituirana raztopina je stabilna 3 dni pri temperaturi 20−25 °C, če jo pred uporabo shranjujemo v originalni viali in/ali injekcijski brizgi.
The reconstituted solution is stable for 8 hours at 20°C-25°C stored in the original vial and/or a syringe.
Rekonstituirana raztopina je stabilna 8 ur pri temperaturi 20−25 °C, če jo pred uporabo shranjujemo v originalni viali in/ali injekcijski brizgi.
The reconstituted solution is to be injected subcutaneously every other day.
Rekonstituirano raztopino je treba injicirati subkutano vsak drugi dan.
The reconstituted solution is to be used immediately.
Rekonstituirano raztopino je treba takoj uporabiti.
The reconstituted solution may be stored at room temperature prior to administration.
Pred uporabo raztopino hranite pri sobni temperaturi.
The reconstituted solution may be stored at up to 25°C for up to 24 hours.
Rekonstituirano raztopino lahko hranite do največ 24 ur pri temperaturi do 25 °C.
The reconstituted solution may be stored for 1 month in a refrigerator at 2°C – 8°C.
Pripravljeno raztopino lahko hranimo v hladilniku pri 2–8 C do 1 meseca.
The reconstituted solution may be stored up to 25°C for up to 24 hours prior to further dilution.
Rekonstituirano raztopino lahko hranite do največ 24 ur pred nadaljnjim redčenjem pri temperaturi do največ 25 °C.
The reconstituted solution must be filtered during administration using a suitable infusion filter (recommended pore size 5 micrometers) and an intravenous administration set (not supplied).
Rekonstituirano raztopino morate med apliciranjem filtrirati z uporabo primernega infuzijskega filtra (priporočena velikost por 5 mikrometrov) in setom za intravensko infundiranje (ni priloženo).
The reconstituted solution must be inspected visually for particulate matter and discolouration prior to administration.
Rekonstituirano raztopino morate pred uporabo vizualno pregledati, da ugotovite, če vsebuje morebitne delce ali če je spremenila barvo.
The reconstituted solution must be used immediately.
Pripravljeno raztopino moramo uporabiti takoj.
The reconstituted solution must be used within 3 hours.
Nota verður tilbúna lausn innan 3 klst.
The reconstituted solution must not be used if discoloured or cloudy or if particulate matter is observed.
Pripravljene raztopine ne smete uporabiti, če je obarvana, motna ali so v njej delci.
The reconstituted solution results in a clear, colourless or slightly yellowish solution, essentially free of visible particles.
Rekonstituirana raztopina je bistra, brezbarvna in nekoliko rumenkasta, praviloma brez vidnih delcev.
The reconstituted solution should be administered by subcutaneous injection once daily, alternating sites between 1 of the 4 quadrants of the abdomen.
Rekonstituirano raztopino je treba dati v obliki subkutane injekcije enkrat na dan, pri čemer je treba menjati vbodna mesta in injicirati v enega od 4 kvadrantov trebuha.
The reconstituted solution should be administered immediately by intravenous injection.
Rekonstituirano raztopino damo bolniku takoj, z intravensko injekcijo.
The reconstituted solution should be checked carefully to ensure that the product is in solution and visually inspected for the absence of particulates prior to use.
Rekonstituirano raztopino je treba pazljivo preveriti in se prepričati, da je zdravilo v raztopini in jo pred uporabo vizualno prekontrolirati, da v njej ni vidnih delcev.
The reconstituted solution should be clear or slightly opalescent, yellow to colourless.
Rekonstituirana raztopina mora biti bistra ali nekoliko opalescentna, rumena do brezbarvna.
The reconstituted solution should be clear to slightly opalescent, i.e. it might sparkle when held up to the light but must not contain any obvious particles.
Pripravljena raztopina mora biti bistra do rahlo svetlikajoča, t.j. lahko se svetlika, če jo držite proti svetlobi, vendar v njej ne sme biti vidnih delcev.
The reconstituted solution should be clear to slightly opalescent, yellow to colourless i.e. it might sparkle when held up to the light but must not contain any obvious particles.
Pripravljena raztopina mora biti bistra do rahlo svetlikajoča, rumena do brezbarvna t.j. lahko se svetlika, če jo držite proti svetlobi, vendar v njej ne sme biti vidnih delcev.
The reconstituted solution should be further diluted in glucose 50 mg/ml (5%) intravenous infusion bag immediately.
Rekonstituirano raztopino nadalje takoj razredčite v vreči za intravensko infuzijo z glukozo 50 mg/ml (5-%).
The reconstituted solution should be inspected visually for particulate matter and/or discolouration prior to administration.
Rekonstituirano raztopino je treba pred uporabo pregledati, ali so prisotni delci in/ali se je pojavilo razbarvanje.
The reconstituted solution should be inspected visually for particulate matter before administration.
Rekonstituirano raztopino pred uporabo s prostim očesom preglejte za tujke in spremembo barve.
The reconstituted solution should be transferred from the vial into the infusion bag immediately.
Rekonstituirano raztopino je treba iz viale takoj prenesti v infuzijsko vrečko.
The reconstituted solution should be transferred from the vial to the infusion bag or bottle immediately.
Pripravljeno raztopino morate iz viale takoj prenesti v infuzijsko vrečo ali steklenico.
The reconstituted solution should be used immediately after preparation.
Rekonstituirano zdravilo je treba porabiti takoj po raztapljanju.
The reconstituted solution should not be administered if it contains particles or is not clear.
Pripravljene raztopine ne smete injicirati, če vsebuje delce ali ni bistra.
The reconstituted solution should not be frozen.
Pripravljene raztopine ne zamrzujte.
The reconstituted solution, if not used immediately must be :
Če rekonstituirana raztopina ni uporabljena takoj, jo je treba:
The reconstituted solution, if not used immediately, should be protected from direct sunlight and stored refrigerated at 2C -8C.
Če pripravljena raztopina ni uporabljena takoj, jo je treba zaščititi pred neposredno sončno svetlobo in shraniti v hladilniku pri temperaturi od 2 C do 8 C.
The reconstituted solutions should be inspected visually for particulate matter and discolouration prior to administration, whenever the container permits.
Če ovojnina to omogoča, je treba pripravljeno raztopino pred infundiranjem vizualno pregledati, da ne vsebuje delcev in da ni spremenila barve.
The reconstituted suspension in the intravenous drip may be stored for up to 8 hours at a temperature not above 25ºC.
Rekonstituirana suspenzija za intravensko dajanje z intravensko kanilo se lahko shranjuje do 8 ur pri temperaturi do 25 ºC.
The reconstituted vaccine contains an inactivated porcine circovirus type 2 (PCV2) in an oily adjuvant (o/w).
Pripravljeno cepivo vsebuje inaktiviran prašičji cirkovirus tipa 2 (PCV2), pomožna snov je oljnata (olje/voda).
The reconstituted vaccine is a homogeneous white emulsion
Rekonstituirano cepivo je homogena bela emulzija.
The reconstituted vaccine is a homogeneous white emulsion.
Pripravljeno cepivo je homogena bela emulzija.
The reconstituted vaccine is slightly more turbid than the solvent and is milky white in appearance.
Rekonstituirano cepivo je nekoliko bolj motno kot vehikel in mlečno belo.
The reconstituted vaccine is transparent to opaque white-yellowish suspension depending on the volume of water used for dilution.
Rekonstituirano cepivo je prozorna do motna belorumena suspenzija, ki je odvisna od prostornine vode, ki se uporabi za redčenje.
The reconstituted vial should be used immediately.
Pripravljeno vialo je treba uporabiti takoj.
The reconstituted vial with 10 mL of 0.9% sodium chloride (normal saline) for injection contains 11.5 mmol (265 mg) of sodium.
Viala, pripravljena (rekonstituirana) z 10 ml 0,9 % natrijevega klorida (fiziološke raztopine) za injiciranje, vsebuje 11,5 mmol (265 mg) natrija.
The reconstituted vials and/or diluted intravenous bags may be stored for a cumulative time of up to 24 hours in a refrigerator (2°C – 8°C).
Pripravljene viale in/ali vrečke z razredčeno raztopino za intravensko uporabo so lahko shranjene v hladilniku (2 °C - 8 °C) do skupno 24 ur.
The reconstituted volume allows accurate withdrawal of 10.0 ml (equal to 400 units) from each vial.
Volumen pripravljene raztopine v eni viali zadošča za natančen odvzem nominalnega volumna, ki je 10,0 ml (ustreza 400 enotam).
The reconstituted volume allows accurate withdrawal of 10.0 ml (equal to 50 mg) from each vial.
Rekonstituirana količina omogoča natančen odvzem 10,0 ml (enakovredno 50 mg) iz vsake viale.
The reconstituted volume allows accurate withdrawal of 10.0 ml (equal to 50 mg) from each vial.
Rekonstituirana vsebina omogoča natančen odvzem 10,0 ml (kar odgovarja 50 mg) iz vsake viale.
The reconstituted volume allows accurate withdrawal of 5.0 ml (equal to 200 units) from each vial.
Volumen pripravljene raztopine v eni viali zadošča za natančen odvzem nominalnega volumna, ki je 5,0 ml (ustreza 200 enotam).
The reconstituted Xiapex solution can be kept at room temperature (20º to 25ºC) for up to one hour or refrigerated at 2º to 8°C for up to 4 hours prior to administration.
Rekonstituirano raztopino zdravila Xiapex lahko hranite pri sobni temperaturi (20 º do 25 ºC) največ eno uro ali v hladilniku pri temperaturi 2 º do 8 °C največ 4 ure pred aplikacijo.
The reconstituted Xiapex solution should be clear.
Rekonstituirana raztopina zdravila Xiapex mora biti bistra.
The reconstituted, filtered and diluted suspension for infusion is a homogenous, white to off-white, opaque liposomal suspension, free of visible particles and free of foam and lipid lumps.
Rekonstituirana, filtrirana in razredčena suspenzija za infundiranje je homogena, bela do sivo-bela motna liposomska suspenzija brez vidnih delcev ter pene in lipidnih kroglic.
The reconstituted/diluted solution should be inspected visually for particulate matter and discolouration.
Preglejte, ali rekonstituirana/razredčena raztopina vsebuje delce in ali je barva spremenjena.
The reconstitution time can be up to 5 mins.
Čas rekonstitucije je lahko do 5 minut.
The record of Cystadane’s designation as an orphan medicine is available here.
Zapis o določitvi zdravila Cystadane kot zdravila sirote najdete tukaj.
The recovery of cytotoxic T-lymphocytes and natural killer cells occurs within 3 to 12 months.
Popravljanje koncentracij citotoksičnih T- limfocitov in naravnih celic ubijalk se pojavi v 3 do 12 mesecih.
The recovery of hypoglycaemia may be delayed because Toujeo has a long action.
Okrevanje po hipoglikemiji je zaradi dolgega delovanja zdravila Toujeo lahko upočasnjeno.
The recovery of the total radioactivity in faeces and urine following administration of 14C-tigecycline indicates that 59 % of the dose is eliminated by biliary/faecal excretion, and 33 % is excreted in urine.
Prestrežena celotna radioaktivnost v blatu in urinu po danem odmerku 14C-tigeciklina kaže, da se 59 % odmerka izloči iz telesa z žolčem in blatom, 33 % pa se ga izloči z urinom.
The red light source provided either a narrow spectrum around 630 nm at a light dose of 37 J/cm2 (Aktilite CL 128) or a broader and continuous spectrum in the range between 570 and 670 nm at a light dose of 170 J/cm2 (Photodyn 750).
Vir rdeče svetlobe je zagotovil bodisi ozek spekter z valovno dolžino okoli 630 nm in odmerkom svetlobe 37 J/cm2 (Aktilite CL 128) bodisi širši in kontinuirani spekter z valovno dolžino v razponu od 570 do 670 nm in odmerkom svetlobe 170 J/cm2 (Photodyn 750).
The reduced doses for patients with renal impairment are expected to achieve the same AUC as that seen in patients with creatinine clearance of 75 ml/min.
Znižani odmerki za bolnike z okvaro ledvic naj bi dosegli enako AUC, kot jo opisujejo pri bolnikih z očistkom kreatinina 75 ml/min.
the reduced loperamide plasma
loperamidove koncentracije v
The reduced risk of cardiotoxicity has also been shown in a retrospective analysis in patients who had received prior adjuvant doxorubicin (log-rank P=0.001, Hazard Ratio=5.42).
Zmanjšano tveganje za srčno toksičnost je pokazala tudi retrospektivna analiza pri bolnicah, ki so prej prejemale adjuvantno zdravljenje z doksorubicinom (log-rang P = 0,001, razmerje tveganja = 5,42).
The reduction from baseline in mean DAS28 score at day 365 (- 3.06) was maintained through day 729 (-3.34) in those patients who continued with abatacept.
Pri bolnikih, ki so nadaljevali zdravljenje z abataceptom, se je zmanjšanje vrednosti povprečne ocene DAS28 od izhodišča do 365. dneva (-3,06) ohranilo do 729. dneva (-3,34).